Clinical Trial Update: Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating fulvestrant and/or anastrozole for postmenopausal patients with stage II-III estrogen receptor-positive, HER2-negative breas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer
• Invasive Ductal Breast Carcinoma
• Invasive Lobular Breast Carcinoma

Drugs mentioned

• Anastrozole (Anastrozole)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING